Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Keyphrases

• India 100%
• Fibrillation 100%
• Anticoagulants 100%
• Risk Profile 100%
• 1-year Outcome 100%
• New-onset Atrial Fibrillation 100%
• Asian Patients 42%
• Diabetes 28%
• Coronary Artery Disease 28%
• Newly Diagnosed 28%
• International Normalized Ratio 28%
• Non-valvular Atrial Fibrillation 28%
• Vitamin K Antagonists 28%
• Clinical Outcomes 14%
• Risk Factors 14%
• Hypertension 14%
• Treatment Patterns 14%
• Confidence Interval 14%
• Clinical Trials 14%
• Ratio Values 14%
• Etiology 14%
• Clinical Profile 14%
• All-cause Mortality 14%
• Unique Identifier 14%
• Baseline Characteristics 14%
• Antithrombotic Therapy 14%
• Antiplatelet Therapy 14%
• Major Bleeding 14%
• Rest of the World 14%
• Working Diagnosis 14%
• Stroke Risk 14%
• Oral Anticoagulant Therapy 14%
• Anticoagulant Therapy 14%
• Registry Data 14%
• Non-interventional 14%
• Global Averaging 14%
• Systemic Embolism 14%
• Global Prevalence 14%
• High Stroke Risk 14%

Medicine and Dentistry

• Antithrombotic 100%
• Atrial Fibrillation 100%
• Fibrillation 100%
• Apoplexy 50%
• Diabetes 33%
• Coronary Artery Disease 33%
• Anticoagulant Therapy 33%
• Vitamin K Antagonist 33%
• Prevalence 16%
• Clinical Trial 16%
• Antiplatelet 16%
• Major Bleeding 16%
• All Cause Mortality 16%

Biochemistry, Genetics and Molecular Biology

• Atrial Fibrillation 100%
• Vitamin K 66%
• Prevalence 33%
• Clinical Trial 33%
• Anticoagulation 33%
• All Cause Mortality 33%